Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells

Monica Bodogai(National Institute on Aging), Kanako Moritoh(National Institute on Aging), Catalina Lee-Chang(National Institute on Aging), Christine Hollander(National Cancer Institute), Cheryl A. Sherman‐Baust(National Institute on Aging), Robert P. Wersto(National Institute on Aging), Yoshihiko Araki(Chiba University), Ichiro Miyoshi(Nagoya City University), Yang Li(National Cancer Institute), Giorgio Trinchieri(Frederick National Laboratory for Cancer Research), Arya Biragyn(National Institute on Aging)
Cancer Research
July 16, 2015
Cited by 174Open Access
Full Text

Abstract

Myeloid-derived suppressive cells (MDSC) have been reported to promote metastasis, but the loss of cancer-induced B cells/B regulatory cells (tBreg) can block metastasis despite MDSC expansion in cancer. Here, using multiple murine tumor models and human MDSC, we show that MDSC populations that expand in cancer have only partially primed regulatory function and limited prometastatic activity unless they are fully educated by tBregs. Cancer-induced tBregs directly activate the regulatory function of both the monocyte and granulocyte subpopulations of MDSC, relying, in part, on TgfβR1/TgfβR2 signaling. MDSC fully educated in this manner exhibit an increased production of reactive oxygen species and NO and more efficiently suppress CD4(+) and CD8(+) T cells, thereby promoting tumor growth and metastasis. Thus, loss of tBregs or TgfβR deficiency in MDSC is sufficient to disable their suppressive function and to block metastasis. Overall, our data indicate that cancer-induced B cells/B regulatory cells are important regulators of the immunosuppressive and prometastatic functions of MDSC.


Related Papers

No related papers found

Powered by citation graph analysis